Dialysis Products

Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency anemia, secondary hyperparathyroidism and hemodialysis throughout the U.S. and abroad. Learn more 

Bio-Pharma Development Program

The company’s lead bio-pharmaceutical iron drug Triferic was commercially launched in the U.S. September 2015 and is designed to prevent and treat iron deficiency anemia in end-stage renal disease patients.
Learn more 

Kidney Disease

Diseases of the kidney are a major health concern in the United States, affecting more than 30 million Americans and causing more than 100,000 deaths annually. Learn more 

Investor Center
Rockwell Medical's common shares are traded on NASDAQ under the symbol RMTI. More ››

About Us

Rockwell is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. As an established manufacturer and leader in delivering high-quality hemodialysis concentrates to dialysis providers and distributors in the U.S. and abroad, Rockwell provides products used to maintain human life, removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. More »